K. Batyrbekov¹, A. Galiakbarova¹

1. «National Research Oncology Center» LLP, Astana, the Republic of Kazakhstan

DOI: https://www.doi.org/10.52532/2521-6414-2023-4-70-34-38

UDC: 616-006.66-072.1

Year: 2023 issure: 70 number: 4 pages: 34-38

Download PDF:

ABSTRACT

Relevance: In recent years, significant breakthroughs have occurred in the endoscopic treatment of cancerous and precancerous lesions of the gastrointestinal tract. Endoscopic mucosal resection (EMR) is a simple and effective method of treating most benign gastrointestinal tract lesions. However, with the introduction of endoscopic submucosal dissection (ESD) and full-thickness endoscopic resection (EFTR), the volume of lesions subject to endoscopic treatment has significantly expanded even in the colon. Currently, these methods are regularly used not only for the treatment of benign tumors but also for complex resection of early stages of colorectal cancer. For the first time in Kazakhstan, the presented article analyzed the cases of endoscopic removal of epithelial formations of the large intestine performed at an oncological clinic from 2020 to 2023.
The aim was to evaluate the use of endoscopic treatment of early colorectal cancer.
Methods: The article presents a retrospective analysis of 68 cases of endoscopic removal of epithelial formations of the colon performed from 2020 to 2023 at the Center of Expert Endoscopy and Interventional Radiology of the National Scientific Cancer Center (Astana, Kazakhstan).
Results: In 2020-2023, 68 endoscopic extractions of colon tumors were performed, including 25 outpatient and 43 inpatient manipulations. Out of 43 inpatient cases, endoscopic dissection in the submucosal layer was performed in 9 cases, and endoscopic mucosal resection of tumors of the large intestine was performed in 34 cases. Morphologically, we found hyperplastic polyps in 11 cases, lipomas in 2 cases, tubulovillous adenomas with mild dysplasia – 43 cases, tubulovillous adenomas with severe dysplasia – 11 cases, carcinoma in situ – 3 cases, and adenocarcinoma with invasion – 3 cases.
Conclusion: When detecting benign neoplasms with dysplasia and early colorectal cancer, minimally invasive technologies (EMR, ESD, EFTR) should be the first preferred treatment method and only if they cannot be performed and there is a high risk of invasion into the underlying layers, and therefore, if endoscopic treatment is not radical, clinicians should choose surgical radical treatment. Patients should be informed about the availability of the latest methods of local treatment in the Republic through the financing of the Compulsory Medical Insurance Fund (CMIF).
Keywords: early colorectal cancer, endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), full-thickness endoscopic resection (EFTR), lateral spreading tumor (LST).

List of sources used:

1. Ebigbo A., Probst A.,Messmann H. Endoscopic treatment of early colorectal cancer – just a competition with surgery? // Innov. Surg. Sci. – 2017. – Vol. 3(1). – P. 39-46. https://doi.org/10.1515/iss-2017-0037
2. Tanaka S., Kashida H., Saito Y., Yahagi N., Yamano H., Saito S., Hisabe T., Yao T., Watanabe M., Yoshida M., Saitoh Y., Tsuruta O., Sugihara K.-i., Igarashi M., Toyonaga T., Ajioka Y., Kusunoki M., Koike K., Fujimoto K. Tajiri H. Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection // Dig. Endosc. – 2020. – Vol. 32(2). – P. 219-239. https://doi.org/10.1111/den.13545
3. Ahmed N., Bechara R. Endoscopic submucosal dissection and JNET classification for colorectal neoplasia: A North American academic center experience // DEN Open. – 2023. – Vol. 4(1). – Art. no. e322. https://doi.org/10.1002/deo2.322
4. Joo H.J., Seok J.U., Kim B.C., Lee D.E., Kim B., Han K.S., Hong C.W., Sohn D.K., Lee D.W., Park S.C., Chang H.J., Oh J.H. Effects of prior endoscopic resection on recurrence in patients with T1 colorectal cancer who underwent radical surgery // Int. J. Colorectal. Dis. – 2023. – Vol. 38(1). – Art. no. 167. https://doi.org/10.1007/s00384-023-04448-z
5. Knoblauch M., Kühn F., von Ehrlich-Treuenstätt V., Werner J., Renz B.W. Diagnostic and Therapeutic Management of Early Colorectal Cancer // Visc. Med. – 2023. – Vol. 39(1). – P. 10-16. https://doi.org/10.1159/000526633